ALISO VIEJO, Calif., Feb. 1, 2008 (PRIME NEWSWIRE) -- SenoRx Inc. (Nasdaq:SENO) today announced it will release its fourth quarter and full-year 2007 financial results on Tuesday, February 19, 2008 prior to the market open. A conference call to review the results will follow at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time). This call will be open to all investors live via the Investor Relations section of the SenoRx Web site at www.senorx.com. A replay of the call will be available on the company's web site approximately 90 minutes after the call concludes. It will also be available to be downloaded as a podcast.
Details:
What: SenoRx's 2007 Fourth Quarter and Full-Year Results Conference
Call and Webcast
Date: Tuesday, February 19
Time: 8:00 a.m. Pacific Time/11:00 a.m. Eastern Time
How: Via telephone: Domestic: 888-215-6899;
International: 913-312-0977
Via Internet: www.senorx.com
About SenoRx
SenoRx (Nasdaq:SENO) develops, manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis and treatment of breast cancer, including its flagship EnCor(r) system and Contura(tm) MLB. SenoRx's field sales organization serves over 1,000 breast diagnostic and treatment centers in the United States and Canada. With 18 products having received FDA 510(k) clearance across the continuum of breast care, SenoRx is developing additional minimally invasive products for diagnosis and treatment of breast cancer. For more information, visit the company's website at www.senorx.com.
The SenoRx, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3605